BNA’s Health Care Daily Report™ sets the standard for reliable, high-intensity coverage of breaking health care news, covering all major legal, policy, industry, and consumer developments in a...
June 14 — Two Chicago-area hospitals can go ahead with a $2.2 billion proposed merger after a federal judge June 14 refused the FTC's request for an order blocking the transaction ( FTC v. Advocate Health Care, N.D. Ill., No. 1:15-cv-11473, 6/14/16 ).
Judge Jorge L. Alonso's refusal to issue an injunction against the merger of Advocate Health Care and NorthShore University HealthSystem allows it to go forward in the face of the Federal Trade Commission's ongoing internal administrative review of the transaction.
The order from the U.S. District Court for the Northern District of Illinois deals the commission its third setback in the past few months, the longest string of losses in hospital merger challenges for the enforcement agency this century. Previous commission challenges to hospital mergers in West Virginia and Pennsylvania failed to stop those mergers either through intervention by the state legislature or by a court order similar to the one in this case.
The commission expressed its disappointment with the court's decision when reached by Bloomberg BNA for comment. “The Court’s ruling is disappointing and we will be considering our options,” said Debbie Feinstein, director of the FTC’s Bureau of Competition, in a statement e-mailed to Bloomberg BNA.
“We couldn’t be more thrilled with the judge’s decision,” Advocate Health Chief Executive Officer Jim Skogsbergh told Bloomberg BNA.
“We are very excited to bring these two organizations together and provide a great low-cost, high-quality product to people all across the Chicago market,” he added.
NorthShore Chief Executive Officer Mark Neaman agreed. “We really believe that today’s decision is precedential, not just in Illinois, but nationally,” he told Bloomberg BNA.
“The court has recognized that we can meet the demands of the Affordable Care Act to provide integrated care and to do so at a lower cost,” he said.
Neaman pointed out that the FTC’s geographic definition had come under fire during the six-day court hearing.
“We have believed since the beginning that the FTC painted a relevant geography that is clearly gerrymandered and not representative of the competitive marketplace that is the Chicago area,” he said.
Additionally, both Neaman and Skogsbergh pointed to the differences in the claims put forward by the commission versus the merger efficiencies touted by the hospitals.
“The FTC made claims about what the future would look like that were very theoretical and the reality was that NorthShore with Advocate was offering a lower-price product that had high-access and high quality of care,” Neaman said.
The executives also emphasized the national attention that the case has received.
“We are well aware that a lot of eyes have been focused on this case,” Skogsbergh said.
“This favorable decision might be a catalyst for more collaboration in the industry and will open up a debate that is positive about how to provide high-quality, low-cost products for our patients,” he added.
The court issued an opinion detailing Alonso's reasoning for denying the injunction, but the judge filed the opinion under seal in an effort to protect any confidential information.
According to his order the parties will have until June 17 to confer and request redactions before the court releases a public version laying bare the court's reasoning for denying the injunction.
“We can't draw lessons as to what's gone wrong until we see the opinion,” Douglas Ross, a partner in Davis Wright Tremaine in Seattle who focuses on antitrust litigation, told Bloomberg BNA.
“The court could have decided it on the basis that the geographic market was too narrow or on the basis that the opportunities for efficiencies the hospitals argued the merger would present are real,” he added.
The West Virginia merger, between Cabell Huntington Hospital and St. Mary's Medical Center in Huntington, W. Va., is currently under review by state regulators after the Legislature in March passed a certificate of public advantage law that was geared toward exempting the merger from federal antitrust laws (61 HCDR, 3/30/16).
The FTC has stopped its internal administrative review of that merger until the state agency concludes its review (81 HCDR, 4/27/16).
Last month, a federal judge in Pennsylvania dealt another blow to the commission, refusing to stop the merger of Penn State Hershey Medical Center and PinnacleHealth System in Harrisburg, Pa. (90 HCDR, 5/10/16).
In that decision, the court rejected the FTC's geographic market definition and cited recent changes in the health-care market generated by the Affordable Care Act as reasons that the merger wasn't anticompetitive.
The commission has appealed that decision to the U.S. Court of Appeals for the Third Circuit, which has scheduled oral arguments for July 26 (95 HCDR, 5/17/16).
The FTC has also delayed its internal review of that merger until “21 days after the United States Court of Appeals for the Third Circuit renders its judgment on the Commission’s appeal.”
In the Chicago case, the FTC hasn't determined whether to halt its administrative review. A final prehearing is scheduled for July 11.
J. Mark Waxman, a partner in Foley & Lardner in Boston who focuses on health care and antitrust litigation, said that the recent losing streak for the FTC might be representative of a new trend.
“It does seem that the standards to be applied are being tested a bit, with perhaps fluidity in the markets and how they should be viewed now upon us,” he told Bloomberg BNA.
However, he cautioned, “with a fact based analysis, you may just have to take these as you—or a federal judge—sees them,” indicating that the recent losing streak may be nothing more than coincidence.
According to Ross, the FTC will have to study the Chicago decision carefully to see whether the reasoning offered by the judge is consistent with the reasoning advanced in the Pennsylvania merger case.
“It's far too early to suggest the FTC should go back to the drawing board—as they did in the early 2000s after losing a string of cases in the 1990s—and figure out what's going wrong,” he added.
Ross said that he thought that the FTC “has an excellent chance of prevailing on appeal before the Third Circuit in Pennsylvania” and that he couldn't guess at how strong the court's decision in the Chicago merger case is until he can read it.
“But obviously the folks at the agency have to be trying to understand, even though all the information is not yet in, whether there are things that they should change as they analyze mergers and decide what to challenge and what not to challenge in the future,” he added.
However, at a recent conference of antitrust and health-care attorneys in Arlington, Va., FTC chair Edith Ramirez seemed undeterred by the Pennsylvania court's decision. Instead, she advocated for increased enforcement of the federal antitrust laws (93 HCDR, 5/13/16).
Advocate Health was represented by Drinker Biddle & Reath LLP and Hogan Lovells LLP.
NorthShore was represented by Winston & Strawn LLP.
Attorneys from the FTC represented the commission and the Illinois Attorney General's Office represented the state.
To contact the reporter on this story: Matthew Loughran in Washington at email@example.com
To contact the editor responsible for this story: Peyton M. Sturges in Washington at firstname.lastname@example.org
The court's order is at http://src.bna.com/fT1.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)